Optimizing Functional‐Domain Integrity of Circular Ribonucleic Acid With Improved Vaccine Immunogenicity by circ Design Algorithm
Authors:
- 22 August 2026
- journal article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (46)
Abstract
Synthetic circular mRNA (hereafter referred to as circRNA) reduces susceptibility to exonuclease‐mediated degradation by its covalently closed circular structure, enabling prolonged protein expression for therapeutic applications. In this circular format, protein expression from engineered circRNAs is achieved mainly through cap‐independent translation initiation, commonly mediated by internal ribosome entry site (IRES) elements whose activity is influenced by RNA structure. Consequently, the coding sequence (CDS) and other elements should be designed with consideration of inter‐region base pairing that can shift IRES folding, a constraint not explicitly addressed by existing linear mRNA CDS optimization algorithms. Here, we present circ Design, an algorithm that explicitly incorporates IRES structural deviation into circRNA sequence design while jointly optimizing codon adaptation and thermodynamic stability. In a rabies virus glycoprotein (RABV‐G) vaccine model, circ Design‐generated circRNAs showed improved stability, translation efficiency, and vaccine immunogenicity compared with benchmark sequences optimized using conventional linear mRNA CDS design strategies, with CR3 achieving a 3.5‐fold increase in neutralizing antibody titers. Polysome profiling and targeted IRES‐disruption experiments support IRES structural integrity as a critical determinant of circRNA translation performance. Together, these results establish IRES structural preservation as a mechanistic design principle for circRNA engineering and position circ Design as a rational framework for therapeutic circRNA development.Keywords
Funding Information
- National Key Research and Development Program of China (2024YFA0916700)
- National Key Research and Development Program of China (2024YFA0918600)
- National Key Research and Development Program of China (2021YFB3800900)
- National Natural Science Foundation of China (32470995)
- National Natural Science Foundation of China (52233007)
- National Natural Science Foundation of China (22477122)
- National Natural Science Foundation of China (32270627)
- Natural Science Foundation of Beijing Municipality (JQ24007)
This publication has 31 references indexed in Scilit:
- A Computationally Optimized Ribonucleic Acid Circularization Strategy without ByproductsJournal of the American Chemical Society, 2025
- Degradation of circular RNA by the ribonuclease DIS3Molecular Cell, 2025
- Dynamic conformation: Marching toward circular RNA function and applicationMolecular Cell, 2024
- Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)eClinicalMedicine, 2023
- Circular RNA: An emerging frontier in RNA therapeutic targets, RNA therapeutics, and mRNA vaccinesJournal of Controlled Release, 2022
- Structured elements drive extensive circular RNA translationMolecular Cell, 2021
- Circular RNA translation, a path to hidden proteomeWIREs RNA, 2021
- Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in MyogenesisMolecular Cell, 2017
- Toward a structural understanding of IRES RNA functionCurrent Opinion in Structural Biology, 2009
- Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and InhibitorsAngewandte Chemie International Edition, 1998